Viridian Therapeutics Ors Inc (VRDN)
Operating Cash Flow (Statement)
-$105.32M
Quarterly · Period ending: · USD
VRDN Operating Cash Flow (Statement)
Latest reported-$105.32Mperiod ending
Latest reported-$105.32Mperiod ending
VRDN Quarterly Cash from Operations (-$367.70K → -$105.32M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
VRDN operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -105,324,000 | |
| -119,654,000 | |
| -23,754,000 | |
| -84,611,000 | |
| -75,373,000 | |
| -92,653,000 | |
| -73,332,000 | |
| -67,706,000 | |
| -46,058,000 | |
| -45,223,000 | |
| -38,000,000 | |
| -38,983,000 | |
| -45,214,000 | |
| -61,973,000 | |
| -34,042,000 | |
| -20,668,000 | |
| -18,086,000 | |
| -21,042,000 | |
| -16,535,000 | |
| -11,876,000 | |
| -14,631,000 | |
| -11,539,000 | |
| -9,436,000 | |
| -5,095,000 | |
| -6,789,000 | |
| -8,459,000 | |
| -7,806,000 | |
| -9,267,000 | |
| -7,174,000 | |
| -11,809,000 | |
| -8,175,000 | |
| -6,802,000 | |
| -4,506,000 | |
| -7,361,000 | |
| -7,243,000 | |
| -5,663,000 | |
| -7,078,000 | |
| -8,183,000 | |
| -1,877,000 | |
| -1,124,000 | |
| -2,008,000 | |
| -2,222,000 | |
| -1,299,000 | |
| -2,304,000 | |
| -2,186,000 | |
| -1,109,000 | |
| -996,750 | |
| -831,027 | |
| -470,411 | |
| 85,188 | |
| -357,546 | |
| -296,176 | |
| -146,376 | |
| -367,695 |